Evidence map›Paper›PMID 35409236›Full record

ArticleInternational journal of molecular sciences2022

TNF-α Induced Myotube Atrophy in C2C12 Cell Line Uncovers Putative Inflammatory-Related lncRNAs Mediating Muscle Wasting.

Tomasz Powrózek, Dominika Pigoń-Zając, Marcin Mazurek, Michael Ochieng Otieno, Mansur Rahnama-Hezavah, Teresa Małecka-Massalska

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Tomasz PowrózekDepartment of Human Physiology, Medical University of Lublin, 20-080 Lublin, Poland.ORCID 0000-0001-9174-8548
Dominika Pigoń-ZającDepartment of Human Physiology, Medical University of Lublin, 20-080 Lublin, Poland.ORCID 0000-0002-7545-3237
Marcin MazurekDepartment of Human Physiology, Medical University of Lublin, 20-080 Lublin, Poland.ORCID 0000-0002-4040-0450
Michael Ochieng OtienoHaematological Malignancies H12O Clinical Research Unit, Spanish National Cancer Research Centre, 28029 Madrid, Spain.
Mansur Rahnama-HezavahChair and Department of Dental Surgery, Medical University of Lublin, 20-093 Lublin, Poland.ORCID 0000-0002-5622-7330
Teresa Małecka-MassalskaDepartment of Human Physiology, Medical University of Lublin, 20-080 Lublin, Poland.ORCID 0000-0003-3384-0324
Medical University of Lublin · PLSpanish National Cancer Research Centre · ES

Funding

National Science Center MINIATURA 2019/03/X/NZ2/00501
6 · The paper itself

Abstract

backgroundMuscle atrophy is a complex catabolic condition developing under different inflammatory-related systemic diseases resulting in wasting of muscle tissue. While the knowledge of the molecular background of muscle atrophy has developed in recent years, how the atrophic conditions affect the long non-coding RNA (lncRNAs) machinery and the exact participation of the latter in the mediation of muscle loss are still unknown. The purpose of the study was to assess how inflammatory condition developing under the tumor necrosis factor alpha (TNF-α) treatment affects the lncRNAs' expression in a mouse skeletal muscle cell line. MATERIALS AND

methodA C2C12 mouse myoblast cell line was treated with TNF-α to develop atrophy, and inflammatory-related lncRNAs mediating muscle loss were identified. Bioinformatics was used to validate and analyze the discovered lncRNAs. The differences in their expression under different TNF-α concentrations and treatment times were investigated.

resultsFive lncRNAs were identified in a discovery set as atrophy related and then validated. Three lncRNAs, Gm4117, Ccdc41os1, and 5830418P13Rik, were selected as being significant for inflammatory-related myotube atrophy. Dynamics changes in the expression of lncRNAs depended on both TNF-α concentration and treatment time. Bioinformatics analysis revealed the mRNA and miRNA target for selected lncRNAs and their putative involvement in the molecular processes related to muscle atrophy.

conclusionsThe inflammatory condition developing in the myotube under the TNF-α treatment affects the alteration of lncRNAs' expression pattern. Experimental and bioinformatics testing suggested the prospective role of lncRNAs in the mediation of muscle loss under an inflammatory state.

Indexed as

RNA, Long NoncodingTumor Necrosis Factor-alphaAnimalsCell LineMiceMuscle Fibers, SkeletalMuscle, SkeletalMuscular AtrophyProspective StudiesRNA, Long NoncodingTumor Necrosis Factor-alphainflammationlncRNAmuscle atrophyTNF-α

Identifiers

PMID35409236
PMCPMC8998797
OpenAlexW4220847194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.